Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% above its 1-year average of -1102.45%, near the high end of its 1-year range (-5612.26%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -1102.45%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
-1102.45%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Oculis Holding AG
Market Cap
$494.32M
Gross Margin
0.00%
TTM Avg
-1102.45%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$500.26M
Gross Margin
74.23%
TTM Avg
74.56%
3Y Avg
72.89%
5Y Avg
72.29%
Market Cap
$488.38M
Gross Margin
74.83%
TTM Avg
73.30%
3Y Avg
73.96%
5Y Avg
75.53%
Market Cap
$509.10M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
-2215.86%
5Y Avg
-1460.58%
Market Cap
$472.88M
Gross Margin
33.94%
TTM Avg
26.16%
3Y Avg
30.65%
5Y Avg
37.85%
Market Cap
$474.59M
Gross Margin
52.05%
TTM Avg
54.84%
3Y Avg
54.67%
5Y Avg
54.23%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $494.32M | 0.00% | -1102.45% | 0.00% | 0.00% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.26M | 74.23% | 74.56% | 72.89% | 72.29% |
| Puma Biotechnology, Inc. (PBYI)vs › | $488.38M | 74.83% | 73.30% | 73.96% | 75.53% |
| Evolus, Inc. (EOLS)vs › | $487.52M | 66.25% | 66.66% | 65.82% | 64.54% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.10M | 0.00% | 50.00% | -2215.86% | -1460.58% |
| 908 Devices Inc. (MASS)vs › | $510.17M | 49.79% | 48.93% | 50.95% | 52.39% |
| Alpha Teknova, Inc. (TKNO)vs › | $472.88M | 33.94% | 26.16% | 30.65% | 37.85% |
| Cerus Corporation (CERS)vs › | $474.59M | 52.05% | 54.84% | 54.67% | 54.23% |
| Arvinas, Inc. (ARVN)vs › | $475.20M | 96.43% | 99.01% | 99.50% | 99.67% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.89M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | -5612.26% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | -2065.93% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
